These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11134094

  • 1. The effect of low dose micronized 17ss-estradiol on bone turnover, sex hormone levels, and side effects in older women: a randomized, double blind, placebo-controlled study.
    Prestwood KM, Kenny AM, Unson C, Kulldorff M.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4462-9. PubMed ID: 11134094
    [Abstract] [Full Text] [Related]

  • 2. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
    Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M.
    JAMA; 2003 Aug 27; 290(8):1042-8. PubMed ID: 12941676
    [Abstract] [Full Text] [Related]

  • 3. Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period.
    Nguyên-Pascal ML, Thomas JL, Bergougnoux L, Garnero P, Drapier-Faure E, Delmas PD.
    Climacteric; 2005 Jun 27; 8(2):136-45. PubMed ID: 16096169
    [Abstract] [Full Text] [Related]

  • 4. Low dose estrogen and calcium have an additive effect on bone resorption in older women.
    Prestwood KM, Thompson DL, Kenny AM, Seibel MJ, Pilbeam CC, Raisz LG.
    J Clin Endocrinol Metab; 1999 Jan 27; 84(1):179-83. PubMed ID: 9920080
    [Abstract] [Full Text] [Related]

  • 5. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.
    J Clin Endocrinol Metab; 1999 Jul 27; 84(7):2390-7. PubMed ID: 10404809
    [Abstract] [Full Text] [Related]

  • 6. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
    Azizi G, Hansen A, Prestwood KM.
    Endocr Res; 2003 May 27; 29(2):133-40. PubMed ID: 12856800
    [Abstract] [Full Text] [Related]

  • 7. The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer.
    Taxel P, Fall PM, Albertsen PC, Dowsett RD, Trahiotis M, Zimmerman J, Ohannessian C, Raisz LG.
    J Clin Endocrinol Metab; 2002 Nov 27; 87(11):4907-13. PubMed ID: 12414849
    [Abstract] [Full Text] [Related]

  • 8. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
    Murphy MG, Bach MA, Plotkin D, Bolognese J, Ng J, Krupa D, Cerchio K, Gertz BJ.
    J Bone Miner Res; 1999 Jul 27; 14(7):1182-8. PubMed ID: 10404019
    [Abstract] [Full Text] [Related]

  • 9. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
    Arrenbrecht S, Boermans AJ.
    Osteoporos Int; 2002 Jul 27; 13(2):176-83. PubMed ID: 11908492
    [Abstract] [Full Text] [Related]

  • 10. The short-term effects of conjugated estrogen on bone turnover in older women.
    Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos LJ, Raisz LG.
    J Clin Endocrinol Metab; 1994 Aug 27; 79(2):366-71. PubMed ID: 8045949
    [Abstract] [Full Text] [Related]

  • 11. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
    Alexandersen P, Riis BJ, Christiansen C.
    J Clin Endocrinol Metab; 1999 Sep 27; 84(9):3013-20. PubMed ID: 10487657
    [Abstract] [Full Text] [Related]

  • 12. The effect of short-term treatment with micronized estradiol on bone turnover and gonadotrophins in older men.
    Taxel P, Kennedy D, Fall P, Willard A, Shoukri K, Clive J, Raisz LG.
    Endocr Res; 2000 Aug 27; 26(3):381-98. PubMed ID: 11019903
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
    Uebelhart B, Herrmann F, Pavo I, Draper MW, Rizzoli R.
    J Bone Miner Res; 2004 Sep 27; 19(9):1518-24. PubMed ID: 15312253
    [Abstract] [Full Text] [Related]

  • 15. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ, MK-677/Alendronate Study Group.
    J Clin Endocrinol Metab; 2001 Mar 27; 86(3):1116-25. PubMed ID: 11238495
    [Abstract] [Full Text] [Related]

  • 16. Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
    Grinspoon SK, Friedman AJ, Miller KK, Lippman J, Olson WH, Warren MP.
    J Clin Endocrinol Metab; 2003 Aug 27; 88(8):3651-6. PubMed ID: 12915650
    [Abstract] [Full Text] [Related]

  • 17. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.
    J Bone Miner Res; 1998 Sep 27; 13(9):1431-8. PubMed ID: 9738515
    [Abstract] [Full Text] [Related]

  • 18. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD.
    J Clin Endocrinol Metab; 1994 Dec 27; 79(6):1693-700. PubMed ID: 7989477
    [Abstract] [Full Text] [Related]

  • 19. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 27; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.